Answers are grounded in this paper and cite their sources.
Demonstrates how isorhamnetin protects cardiac health from organophosphate damage, indicating a potential therapeutic approach.
Isorhamnetin alleviates CPF-induced cardiotoxicity by restoring redox balance and modulating inflammatory and apoptotic pathways through Nrf2/HO-1 signalling.
No takes yet. Share an insight, caveat, or question.
Bseiso et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: